Shareholders approve all motions at the 84th Ordinary General Meeting

Zurich, Switzerland, March 23, 2017 - DKSH, the leading Market Expansion Services provider with a focus on Asia, announced today that its 84th Ordinary General Meeting voted in favor of all proposals by the Board of Directors. In total 236 shareholders (84.3% of share capital) were present at the meeting.

The shareholders approved the Financial Statements and the Group Consolidated Financial Statements for the financial year 2016 as well as the appropriation of available earnings as per balance sheet 2016.

Shareholders approved the payout of dividends. The distribution of an ordinary dividend of CHF 1.50 per share (total value: CHF 97.6 million) and an extraordinary dividend of CHF 3.00 per share (total value: CHF 195.1 million) starts as of March 29, 2017.

The shareholders granted discharge from liability to each member of the Board of Directors and of the Executive Board for the financial year 2016. The maximum compensation of the members of the Board of Directors for 2017 and of the Executive Board for 2018 has been approved.

All Directors of the Board of DKSH - namely Adrian T. Keller, Rainer-Marc Frey, Dr. Frank Ch. Gulich, David Kamenetzky, Andreas W. Keller, Robert Peugeot, Dr. Theo Siegert, Dr. Hans Christoph Tanner and Dr. Joerg Wolle - were reelected for a term of office until completion of the next Ordinary General Meeting.

Dr. Joerg Wolle was elected as Chairman of the Board for the same time period. In addition, the Board of Directors designated Adrian T. Keller as its honorary chairman.

Adrian T. Keller as well as the former members Dr. Frank Ch. Gulich and Robert Peugeot were elected for the Nomination and Compensation Committee.

Ernst & Young Ltd., Zurich was re-appointed as DKSH's Statutory Auditors for the financial year 2017. Ernst A. Widmer was re-elected as Independent Proxy until completion of the next Ordinary General Meeting.

The new DKSH Chairman Dr. Joerg Wolle said: "We set ourselves ambitious targets last year which, in spite of challenging economic conditions, we not only achieved, but exceeded. The record year 2016 is an outstanding performance by our employees. The strong result is another proof of the resilience of our business model. We ensure continuity by systematically implementing our successful strategy. As the clear market leader in Asia we are confident to make the changes at the top of the company happen from a position of strength and to continue our path of sustainable and profitable growth."

As already announced end-2016, following today's Annual General Meeting, the DKSH Executive Board consists of:

• Stefan Butz, Chief Executive Officer (CEO): responsibility for the entire operational business
• Bernhard Schmitt, Chief Financial Officer (CFO)
• Martina Ludescher, Chief Commercial Officer (CCO)
• Stephen Ferraby, Head Corporate Affairs & Strategic Investments

The DKSH Group Management team further on includes the following persons:

• Andrew Frye, Head Business Unit Healthcare
• Thomas Sul, Co-Head Business Unit Performance Materials
• Dr. Natale Capri, Co-Head Business Unit Performance Materials
• Hanno Elbraechter, Head Business Unit Technology
• Christopher Pollard, Head Supply Chain Management

Further information about the DKSH-Management team are available on the DKSH webpage at Executive Board and Group Management.